| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Metabolic syndrome, olanzapine-induced, in rmouse (C57BL/6)
|
AB66095 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, Prkaa2 knockout/high-fat diet-induced, in mouse (C57BL/6)
|
AB66096 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, transgenic (Mtch2-GFP)/high-fat diet-induced, in mouse (C57BL/6)
|
AB66097 |
mouse |
Metabolic syndrome |
|
Metabolic syndrome, transgenic (Rock2)/high-fat diet-induced, in mouse (C57BL/6)
|
AB66098 |
mouse |
Metabolic syndrome |
|
Metastatic cancer (to bone), xenograft (EO771 transfected with luciferase), in mouse (C57BL/6)
|
AB66099 |
mouse |
Cancer,metastatic (to bone) |
|
Metastatic cancer (to liver), xenograft (KPC), in mouse (C57BL/6)
|
AB66100 |
mouse |
Cancer,metastatic (to liver) |
|
Metastatic cancer (to lung), allograft (B16 (Sra1-knockdown)), in mouse (C57BL/6)
|
AB66101 |
mouse |
Cancer,metastatic (to lung) |
|
Metastatic cancer (to lung), allograft (Mammary cancer cells, mouse (MMTV-PyMT-transgenic)), in mouse (C57BL/6)
|
AB66102 |
mouse |
Cancer,metastatic (to lung) |
|
Metastatic cancer (to lung), allograft B78/B16F10, in mouse (C57BL/6)
|
AB66103 |
mouse |
Cancer,metastatic (to lung) |
|
Metastatic cancer (to lung), Furin T-lymphocytes conditional knockout/patient-derived xenograft (Breast cancer cells, human (triple-negative)), in mouse (C57BL/6)
|
AB66104 |
mouse |
Cancer,metastatic (to lung) |